Patents by Inventor Matthew WESTMORELAND

Matthew WESTMORELAND has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220087870
    Abstract: A dressing for treating a tissue site, which may comprise a tissue interface and a cover comprising an expansion zone configured to be disposed over the tissue interface. The tissue interface may comprise a tissue contact layer having a treatment aperture in some examples. In more particular examples, the cover may be coupled to the tissue contact layer to form an expansion chamber between the expansion zone and the tissue contact layer. The cover may also comprise a base coupled to the tissue contact layer in some examples. Additionally, the tissue interface may further comprise an absorbent disposed within the expansion chamber in some embodiments. In some examples, the absorbent may be a manifold. Additionally or alternatively, the expansion chamber and the absorbent may be detachable.
    Type: Application
    Filed: January 8, 2020
    Publication date: March 24, 2022
    Inventors: Benjamin Andrew PRATT, Matthew WESTMORELAND, James Killingworth SEDDON, Thomas Alan EDWARDS, Christopher Brian LOCKE
  • Publication number: 20210361820
    Abstract: An antimicrobial composition may comprise a surfactant. The antimicrobial composition may include about 30 ?g/ml to about 1,000 ?g/ml of the surfactant, by volume of the antimicrobial composition. The surfactant may comprise a docusate salt such as docusate sodium. The antimicrobial composition may comprise an antimicrobial agent. The antimicrobial composition may include from about 0.01% to about 10% of the antimicrobial agent, by weight of the antimicrobial composition. The antimicrobial agent may comprise polyhexanide (PHMB). In some embodiments, the antimicrobial composition may comprise a matrix-forming material. The antimicrobial composition may include at least 90% of the matrix-forming material, by weight of the antimicrobial composition. The matrix-forming material may comprise collagen, oxidized regenerated cellulose, alginate, carboxymethylcellulose, or combinations thereof.
    Type: Application
    Filed: December 20, 2018
    Publication date: November 25, 2021
    Inventors: Katherine A. BOURDILLON, Craig DELURY, Sophie REGAN, James Sebastian MELLOR, Matthew WESTMORELAND
  • Patent number: 10813982
    Abstract: A composition comprising an oxidoreductase enzyme and a substrate for the enzyme for use in treating or preventing biofilm formation by a population of pathogenic bacteria. The composition can be incorporated into a wound dressing for use in promoting wound healing.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: October 27, 2020
    Inventors: Katie Bourdillon, Matthew Westmoreland, Sophie Regan
  • Publication number: 20180303912
    Abstract: A composition comprising an oxidoreductase enzyme and a substrate for the enzyme for use in treating or preventing biofilm formation by a population of pathogenic bacteria. The composition can be incorporated into a wound dressing for use in promoting wound healing.
    Type: Application
    Filed: October 14, 2016
    Publication date: October 25, 2018
    Inventors: Katie BOURDILLON, Matthew WESTMORELAND, Sophie REGAN